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Oxidative stress critically contributes to the pathogenesis of a variety of neurodegenerative diseases
such as multiple sclerosis. Astrocytes are the main regulators of oxidative homeostasis in the brain
and dysregulation of these cells likely contributes to the accumulation of oxidative damage. The
nuclear factor erythroid 2-related factor 2 (Nrf2) is the main transcriptional regulator of the anti-
oxidant stress defense. In this study, we elucidate the effects of astrocytic Nrf2-activation on brain-
intrinsic inflammation and lesion development. Cells deficient for the Nrf2 repressor
kelch-like ECH-associated protein 1 (Keap1) are characterized by hyperactivation of Nrf2-signaling.
Therefore, wild type mice and mice with a GFAP-specific Keap1-deletion were fed with 0.25%
cuprizone for 1 or 3 weeks. Cuprizone intoxication induced pronounced oligodendrocyte loss,
demyelination and reactive gliosis in wild type animals. In contrast, astrocyte-specific Nrf2-activation
was sufficient to prevent oligodendrocyte loss and demyelination, to ameliorate brain intrinsic
inflammation and to counteract axonal damage. Our results highlight the potential of the Nrf2/ARE
system for the treatment of neuroinflammation in general and of multiple sclerosis in particular.
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Multiple sclerosis (MS) is an inflammatory disorder of the central nervous system (CNS) with a
heterogeneous disease course and complex pathophysiology. Different conflicting concepts have
been proposed to explain disease progression and lesion formation in MS (Mahad et al. 2015).
Although the inflammatory responses greatly differ among distinct MS lesion subtypes, overall data
suggests that considerable brain-intrinsic inflammation and an activation of microglia cells are always
present when active demyelination or neurodegeneration occurs (Frischer et al. 2009; Mahad et al.
2015). Reactive microglia are thought to contribute to tissue damage by the secretion of
inflammatory mediators such as cytokines and chemokines, as well as the production of reactive
oxygen (ROS) and nitrogen species (RNS). Indeed, signs of oxidative damage such as oxidized
phospholipids and malondialdehyde (MDH) in myelin, apoptotic oligodendrocytes, degenerating glia
cells and neurons indicate a critical role of oxidative stress for the pathogenesis of MS lesions (Haider
et al. 2011; Lu et al. 2000; van Horssen et al. 2008). Persistent oxidative stress likely exacerbates the
already deleterious effects of the neuroinflammation itself (Johnson and Johnson 2015; Lassmann
2014; Schuh et al. 2014).
The role of activated astrocytes within damaged brain areas is complex and manifold. Astroglial
(dys)-function can result in demyelination and oligodendrocyte pathology (Sharma et al. 2010).  It is
furthermore documented that activated astrocytes secrete molecules with potentially direct toxic
effects on neurons/axons and oligodendrocytes/myelin, such as ROS and RNS, glutamate, and ATP
(Spray 2011). For example, extensive iNOS reactivity was observed in hypertrophic astrocytes in
acute MS lesions (Liu et al. 2001). Despite this detrimental role, beneficial effects of astrocytes on de-
and remyelination are also discussed. The detoxification of free radicals in the CNS has been linked to
astrocytes in a variety of diseases such as spinal cord ischemia, amyotrophic lateral sclerosis as well
as Parkinson`s and Alexander`s disease (Mena and Garcia de Yebenes 2008).
The nuclear factor erythroid 2-related factor 2 (Nrf2) is a key molecule involved in the transcriptional
regulation of multiple oxidative-stress-related genes in the insulted brain (Dang et al. 2012). Among
activation by oxidative challenge, Nrf2 is released from its repressor
kelch-like ECH-associated protein 1 (Keap1) and translocates into the nucleus where it binds to the
antioxidant response element (ARE), thereby activating the transcription of antioxidant and
detoxifying enzymes (Huang et al. 2015). Pharmacological activation of the Nrf2/ARE system has
proven beneficial in a variety of diseases, among MS (Al-Sawaf et al. 2015; Wruck et al. 2008).
Recently, the dimethyl fumaric acid ester compound dimethyl fumarate (DMF, also known as BG-12,
Fumaderm) was approved for the treatment of relapsing-remitting MS (Kim et al. 2015). Although
the mechanism of action is not completely understood, it has been shown that DMF activates Nrf2-
activity by disruption of the Nrf2 - Keap1 interaction due to a modification at cysteine residue 151 of
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the Keap1 protein (Linker et al. 2011). This leads to increased Nrf2-signaling, both in vivo and in vitro.
However, other mechanisms seem more likely to contribute to DMF efficacy, such as an activation of
Hydroxycarboxylic acid receptor 2 (Chen et al. 2014; Offermanns and Schwaninger 2015). Besides, it
has recently been shown that DMF sufficiently inhibits NF-κB in an Nrf2-independend manner
(Gillard et al. 2015). Further studies are therefore needed to clarify the precise effects of activation of
Nrf2-signaling in distinct cell types and pathologies. As already mentioned for DMF, all known Nrf2-
inducers not only enhance Nrf2-activity but also exert various additional effects within the brain and
peripheral tissues (Fragoulis et al. 2012). Therefore, genetic and cell type specific targeting of Keap1
and/or Nrf2 represents the most suitable method to investigate Nrf2-specific effects.
With respect to MS, experimental autoimmune encephalomyelitis (EAE) is exacerbated in Nrf2-KO
mice, demonstrating the relevance of Nrf2 for autoimmune neuroinflammatory responses (Johnson
et al. 2010). In contrast to EAE, T cells are not the driving pathogenic force in the cuprizone model of
MS (Kipp et al. 2009). This model allows studying the basic mechanisms of de- and remyelination,
since no interference by the peripheral immune system takes place. It is characterized by
reproducible demyelination within both white and gray matter, a selective and pronounced loss of
oligodendrocytes and robust micro- and astrogliosis within damaged brain regions (Clarner et al.
2015; Goldberg et al. 2015; Slowik et al. 2015). Using this model of demyelination, we investigated




Animals were fed a diet containing 0.25% cuprizone (bis-cyclohexanone oxaldihydrazone; Sigma-
Aldrich) in powdered standard rodent chow for the indicated period. Control mice were provided
with standard rodent chow as published previously (Clarner et al. 2015). Animals had free access to
food and water and were housed under standard laboratory and pathogen free conditions according
to the Federation of European Laboratory Animal Science Association’s recommendations. The
procedures were approved by the Review Board for the Care of Animal Subjects of the district
government (North-Rhine Westphalia, Germany) and performed according to international
guidelines on the use of laboratory mice.
Early (1 week cuprizone) and late (3 weeks cuprizone) demyelinating lesions were induced in
different mouse strains on the C57BL/6J background with appropriate littermates as controls (see
below). If not stated otherwise, the current study was conducted with 8 to 16 week old mice. The
following mouse strains were included:
• C57BL/6J ARE luciferase reporter gene mice (Cgene, Oslo) (Dohlen et al. 2008) to visualize
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Nrf2-activation in early lesions (1 week). Untreated C57BL/6J ARE luciferase reporter gene
mice were included as controls.
• GFAP-Cre::keap1
flox/flox KO (referred to as Keap1-KO in this manuscript) mice were generated
by cross-breeding homozygous floxed Keap1
flox/flox
 with mice expressing Cre recombinase
under the control of the glial fibrillary acidic protein (GFAP) promoter. The GFAP-Cre
expressing mouse was kindly provided by Prof. Lüdde (Faculty of medicine, Uniklinik RWTH
Aachen, Germany). The astrocyte-specific expression of the Cre recombinase in this strain
was described in (Bajenaru et al. 2002). Keap1
flox/flox
 animals were already available as Alb-
Cre::Keap1
flox/flox
 strain in our group and were initially provided by Prof. Kensler (Department
of Pharmacology and Chemical Biology, School of Medicine, University of Pittsburgh,
Pittsburgh, PA USA). For cross-breeding, Cre-negative Keap1flox/flox animals were mated with
GFAP-Cre expressing mice. As in this strain’s Cre recombinase is specifically expressed by
astrocytes, these animals lack astrocytic Keap1. This leads to a hyperactivation of the
Nrf2/ARE system in the targeted cells as also demonstrated for hepatocytes by Okawa and
colleagues using an Albumin-driven Cre recombinase (Okawa et al. 2006). There was no
histological phenotype found due to the Keap1 ablation. Cre negative animals with floxed
Keap1 alleles served as controls in this approach. These mice were used to investigate the
protective effects of astrocyte-specific Nrf2/ARE-activation in the brains of mice fed
cuprizone for 3 weeks.
In vivo visualization of ARE-activity
Age and weight-matched littermates (8-16 weeks of age and 19-25g of body weight) were used for
ARE-activity measurements (n = 5/group). Heads were shaved to allow a more sufficient
luminescence imaging through skin and skull. Luciferin injection solution (Synchem OHG, Felsberg/
Altenburg, Germany) was prepared under sterile conditions as published previously (Fet et al. 2014)
and used at a final concentration of 20 mg/mL. 0.2mL luciferin solution was injected intraperitoneally
10 min before narcotization. Mice were anesthetized by inhaling 5% (v/v) isoflurane (AbbVie,
Ludwigshafen, Germany) at a flow rate of 2 L/min oxygen for approximately 1 min and then kept at
1.5% (v/v) and 1 L/min using a mouse face mask. Body temperature was maintained at 37.0 ± 0.5 °C
with an electrical heating pad.
Fifteen minutes after luciferin injection, mice were imaged for 5 min from the dorsal side at
high-resolution settings (binning: 2, f/stop: 1) with a field of view of 7.5 cm. Emitted light was
detected by the IVIS Imaging System 100 Series (Xenogen Corporation, Alameda, CA), digitized and
evaluated using the Living Image software 3.2 (Xenogen Corporation, Alameda, CA). Brain-specific
signals were quantified using defined regions of interest (ROIs). Obtained luminescence signals were
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normalized to the signals of control mice from the very same measurement. Results are thereby
expressed as relative luminescence values (n-fold). The false color scale of the corresponding
measurement and pictures is presented as photons/sec/cm²/sr. Non-specific background signals
were subtracted as published previously (Wruck et al. 2011).
To investigate region specific luciferase-activity in the brain, mice were injected as described above
and killed 10 min later by cervical dislocation. Brains were quickly removed, sliced into 1 mm thick
coronal sections and imaged as described above.
Tissue preparation
For histological and immunohistochemical (IHC) studies, mice were transcardially perfused with 3.7%
paraformaldehyde in 10 mM PBS. After overnight post-fixation in the same fixative, brains were
dissected, embedded in paraffin, and then coronary sectioned into 5 µm sections at the levels 235
and 265 according to the mouse brain atlas of Sidman et al.
(http://www.hms.harvard.edu/research/brain/atlas.html).
For gene expression analysis and lipid peroxidation assays, mice were deeply anesthetized and
transcardially perfused with ice-cold PBS, the brains quickly removed, and the entire corpus callosum
dissected using a stereomicroscopic approach. Isolated tissue was snap-frozen in liquid nitrogen and
kept at −80 °C until further used (Clarner et al. 2015).
Gene expression studies
For this study, a previously published Gene array was re-evaluated focusing on oxidative-stress
pathways and Nrf2-activation (Krauspe et al. 2015). For real time PCR (RT-qPCR) studies, tissue was
homogenized in PeqGold RNA Pure (PeqLab, Germany; cat. no. 30-1010) and RNA isolated according
to the manufacturer's protocols. RNA concentration and purity were photometrically measured on a
NanoDrop 1000 (Thermo Fisher Scientific, USA). Reverse transcription was performed using 1 μg of
total RNA and a MMLV reverse transcriptase kit (Invitrogen, Germany, 28025-013) (Clarner et al.
2014). qRT-PCR utilizing SYBR Green SensiMixTM (Bioline, Germany, QT615-05) was carried out on
the MyIQ RT-PCR detection system (Biorad, Germany) applying the following protocol: 10 min
enzyme activation at 95°C, 40 cycles of 15 s denaturation at 95°C, 30 s annealing at individual
temperatures, 30 s amplification at 72 °C, and 5 s fluorescence measurement at 80°C. Relative
quantification of gene expression was performed with the efficacy-corrected ΔCt method and data
normalized to a reference gene. Primer sequences and annealing temperatures are given in Table 2
(Clarner et al. 2014). For amplification-efficacy determination, external standard curves were
generated by several fold dilutions of cDNA samples used in the respective experiment. The target
gene expression was calculated by comparing relative expression in each sample with respective
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reference gene values. Finally, data was normalized and related to the expression of control groups.
Melting curves and gel electrophoresis of the PCR products were routinely performed to determine
the specificity of the PCR reaction (not shown) (Groebe et al. 2009).
Immunohistochemistry (IHC) and luxol fast blue staining
For IHC, sections were placed on glas slides, deparaffinized, rehydrated, heat unmasked if necessary,
blocked with PBS containing 5% horse or normal goat serum, and incubated overnight at 4 C with the
primary antibody diluted in blocking solution. Primary antibodies and dilutions used in the study are
given in Table 3. After washing and blocking of endogenous peroxidase with 0.3% hydrogen peroxide
(in PBS) for 30 min, sections were incubated with biotinylated secondary horse anti-mouse or goat
anti-rabbit antibody diluted in blocking solution for 1 h, followed by peroxidase-coupled avidin–
biotin complex (ABC kit; Vector Laboratories). The diaminobenzidine reaction (DAKO Deutschland)
was used to visualize peroxidase–avidin–biotin complexes. Sections were counterstained with
standard hematoxylin to visualize cell nuclei. Secondary antibodies and dilutions used are given in
Table 4.
To assess cell-specific expression of Nrf2, immunofluorescence double stainings were performed.
Therefore, slides were blocked with 2% FCS, 0.05% Tween20, 10% BSA, 1% fish gelatine, diluted in
PBS, pH 7.4 and incubated overnight at 4 C with anti-Nrf2 antibody (GeneTex, GTX103322) diluted in
blocking solution. After washing with PBS, sections were exposed to biotinylated secondary goat anti-
rabbit antibody diluted in blocking solution for 1h at RT, followed by Alexa Fluor 488 conjugated
Streptavidin (Thermo Fisher Scientific, s11223) for 30min at RT. In the next step, sections were
incubated overnight at 4°C with the appropriate primary antibody diluted in blocking solution.
Primary antibodies and dilutions used in the study are given in Table 3. After washing, sections were
incubated with an Alexa Fluor 594 conjugated secondary donkey anti-goat or goat anti-mouse
antibody diluted in blocking solution for 1h. Secondary antibodies and dilutions used are given in
Table 4. Sections were counterstained with Hoechst 33342 (Invitrogen, 1:10000) to visualize cell
nuclei. Stained sections were examined and photographed with a Nikon ECLIPSE 80i microscope and
40x objective. Quantification of axonal damage, oligodendrocytes and microglia was performed by
counting amyloid precursor protein (APP) positive bulbs, oligodendrocyte transcription factor (Olig2)-
positive cells and ionized calcium-binding adapter molecule 1 (Iba1)–positive cells, respectively. Two
brain slices from region 235 and two slices from region 265 from each animal were used for analysis.
Counting was performed by at least two independent examiners in a blinded manner. Results were
expressed as number of cells/mm2.
For LFB staining, sections were deparaffinized and hydrated, then incubated in a 0.1% LFB solution
overnight at 56 °C. The next day, the excess of staining solution was rinsed off in 95% ethyl alcohol,
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washed in distilled water and differentiated in 0.05% lithium carbonate solution for 20 s. After this,
PAS staining was performed by oxidizing the slides in 0.5% periodic acid solution for 5 min, rinsing it
in distilled water, and incubating it in Schiff reagent for 15 min. Afterwards, sections were washed in
tap water for 5 min. Slides were cpounterstained with Mayer’s hematoxylin for 1 min. The tissue was
then washed again, dehydrated and mounted in DPX.
Statistics
If not stated otherwise, at least two experimental settings were performed with a group size of ≥ 3
animals each per experiment and experimental group (n ≥ 6). Equal variances and normal distribution
were checked by the Bartlett test and the Shapiro-Wilk test respectively. Intergroup differences of
parametric data were tested either by Student’s t-test (comparison of two groups) or ANOVA
(multiple comparisons), followed by Tukey’s or Bonferroni post hoc tests using GraphPad Prism 5
(GraphPad Software), if not stated otherwise. All data are given as arithmetic means ± SEM. The p
values are indicated as *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001. For further information, see figure
legends.
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Oxidative stress during early cuprizone intoxication
We recently performed genome wide gene expression studies of early cuprizone intoxication (i.e. 2
days) to gain a deeper understanding of the biochemical pathways activated in response to cuprizone
intoxication (Krauspe et al. 2015). In this study, we re-evaluated these data with respect to oxidative
stress reactions and defense mechanisms. As listed in table 1, in 14 gene enrichments related to
oxidative stress responses between 12.8% and 60.0% of the genes belonging to these gene
ontologies showed a significantly altered mRNA expression profile (p < 0.05, FC > 1.25) in the corpus
callosum of cuprizone-fed animals. These results indicate the critical role of oxidative stress in early
lesion development after cuprizone intoxication. The complete list of all regulated genes belonging to
the selected gene ontologies is summarized in the supplementary table 1. To confirm our gene
expression array data at a later time point (i.e. 1 week) and to further investigate, whether the
Nrf2/ARE system is indeed activated in early demyelinating lesions, RT-qPCR for the following genes
was performed: heme oxigenase (Hmox1), glutamate-cysteine ligase, catalytic subunit (GCLC) and
thioredoxin reductase (TxnRD1) (figure 1). The expression of these genes is typically regulated by
Nrf2-binding to the ARE (Brown and Drake 1973; Clovis and Hargreaves 1988; Patenaude et al. 2005).
Gene expression of all three genes was significantly induced after one week cuprizone intoxication
indicating the functional relevance of Nrf2-signaling in the initial oligodendrocyte-stress process
within the corpus callosum.
Activation of the Nrf2/ARE system during early cuprizone intoxication
To further investigate the temporal and quantitative pattern of Nrf2/ARE-activation, we decided to
include transgenic ARE-Luc mice in this study. Among ARE-activation, these mice express a
functionally active luciferase protein (originates from the firefly, lat. photinus pyralis). In this
approach, the luciferase activity directly correlates with Nrf2-activity. Luminescence can thereby be
used as a sufficient measure for Nrf2-activity. Animals were fed cuprizone for up to one week and the
luciferase-activity was measured on a daily basis in vivo. Mice fed normal chow served as controls.
Summarized and normalized data of all experiments is shown in figure 2A. A significant induction of
luciferase-activity was observed in cuprizone-fed mice as early as two days of cuprizone intoxication,
indicating a functional role of Nrf2-activity, at least at this lesion stage. Representative images of the
in vivo bioluminescence analysis using the XENOGEN living image system are depicted in the upper
row of figure 2B. By setting appropriate ROIs, these measurements were used for quantification.
Since the in vivo measurement does not allow a statement about regional differences in ARE
activation, animals were sacrificed at the end of the experiment, frontal brain sections prepared, and
a luminescence measurement conducted. Representative images are shown in figure 2C. These
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experiments revealed the highest luminescence signal within the corpus callosum (CC) white matter
tract, a region which is particularly vulnerable to cuprizone intoxication and therefore one of the best
studied brain regions in this animal model.
Cellular source of Nrf2 in the cuprizone model
In a next set of experiments, we aimed to identify the expression pattern and cellular source of Nrf2
in response to cuprizone intoxication. As shown in figure 3A, the number of Nrf2-positive cells
increased in both 1 and 3 weeks cuprizone groups. Double-staining against Nrf2 and GFAP revealed
that Nrf2-positive astrocytes were present at very low numbers in all investigated groups (figure 3B),
indicating, low stress levels of astrocytes, even due cuprizone-intoxication. In contrast, the number of
Nrf2-positive oligodendrocytes markedly increased within the CC white matter in both 1 and 3 weeks
treated animals (figure 3C).
Over-activation of the astrocytic Nrf2/ARE system protects against cuprizone toxicity
So far we were able to demonstrate that oxidative stress is a characteristic feature of early
cuprizone-induced lesions which is paralleled by the activation of the Nrf2/ARE pathway in
oligodendrocytes. However, since cuprizone induces profound demyelination in a matter of weeks,
the activation of the Nrf2/ARE pathways has to be considered as insufficient to overcome deleterious
effects and act as a protective cellular response. We therefore decided to strengthen this
archetypical cytoprotective pathway by comparing the outcome of wt and Keap1-KO mice after a
prolonged, 3 weeks cuprizone challenge. Since astrocytes are critically involved in the maintenance
of redox homeostasis in the brain (Schreiner et al. 2015), Keap1 was deleted specifically in this
macroglia cell population which results in a genetic model for constitutive activation of the Nrf2/ARE
pathway in astrocytes.
In wild type animals, cuprizone intoxication induced the loss of myelin (visualized by luxol fast blue-
stains, LFB, figure 4A, 1
st
 row) and oligodendrocytes (visualized by anti-Olig2 staining, figure 4A, 2
nd
row), microgliosis (visualized by anti-Iba1 staining, figure 4A, 3
rd
 row) and acute axonal damage
(APP+-spheroids, red arrows, figure 4A, 4
th
 row) (Clarner et al. 2015). In sharp contrast, the loss of
myelin and oligodendrocytes was almost completely prevented in Keap1-KO mice (figure 4A, 3rd
column). Furthermore, the number of microglia cells within the CC was significantly lower in
comparison to treated wild type animals. Histological quantifications of oligodendrocytes, microglia
and APP+-spheroids numbers are shown in figure 4B. These results demonstrate that strengthening
of the Nrf2 system in astrocytes is sufficient to prevent or delay the development of demyelinating
lesions, neuroinflammation and axonal damage.
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Astrocyte reactivity is unchanged in Keap1-KO mice
A characteristic feature of both MS lesions and cuprizone-induced lesions is the accumulation of
reactive astrocytes within the damaged CNS areas (Clarner et al. 2012). In a next set of experiments,
we therefore investigated the activation of astroglia in wild type as well as Keap1-KO mice after
cuprizone intoxication. Data are presented in figure 5. As expected, cuprizone exposure significantly
increased GFAP+ cell numbers in the CC (figures 5A and B). Despite the above mentioned
amelioration of cuprizone toxicity, the increase in astrocyte numbers within the CC was comparable
in both mouse strains and not abolished or dampened in Keap1-KO mice. Since a critical molecule
which is secreted by activated astrocytes and involved in the activation of local microglia in the
cuprizone model is the chemokine CXCL10 (Clarner et al. 2015), we used the expression of CXCL10
mRNA as an indirect indicator to asses astrocyte reactivity. As shown in figure 5B and in accordance
with previous studies (Clarner et al. 2015), cuprizone administration resulted in a significant increase
of CXCL10 expression. This induction was comparable in Keap1-KO mice.
Discussion
In the present study, we demonstrate that cuprizone intoxication induces the Nrf2/ARE system in the
CC and that the genetic hyper-activation of astrocytic Nrf2 is sufficient to prevent oligodendrocyte
loss, microgliosis and axonal damage without affecting astroglial activation in a demyelinating animal
model. Further, we provide a set of cuprizone-dependent oxidative stress-related genes regulated
within the CC.
Relevance of the cuprizone model for studying Nrf2-signaling and neuroinflammation
Neuroinflammation is defined as the brain’s activation of the innate immune system due to external
stimuli or brain-intrinsic responses to injuries. Its main function is to protect the CNS and neuronal
circuits from degeneration and damage and to take care of brain homeostasis under deleterious
conditions. It is well-established that innate immune responses of the brain are actively involved in
the origin and progression of neurological diseases and disorders (Spencer et al. 2012; Zhang and
Jiang 2015). Besides other acute CNS responses to such threatening conditions, oxidative stress
reactions driven by neuroinflammation and the production of ROS and RNS in activated microglia
play a critical role in the propagation of demyelination and neurodegeneration (Gonsette 2008;
Haider et al. 2011; Licht-Mayer et al. 2015; Wang et al. 2014). Nrf2 activation is a highly conserved
adaptive mechanism of eukaryotic cells to prevent oxidative stress and is a well-documented
phenomenon in MS lesions (Licht-Mayer et al. 2015). The induction of Nrf2 and it`s target genes (i.e.
Hmox1) has been demonstrated in oligodendrocytes in initial white matter lesions (Licht-Mayer et al.
2015). In contrast, Nrf2-positive astrocytes and macrophages were mainly found in later stages of
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active lesions (Licht-Mayer et al. 2015). Our findings on 1 and 3 week old cuprizone-induced lesions
confirm the presence of high numbers of Nrf2-positive oligodendrocytes during the active
development of demyelinated lesions. Further studies on the cuprizone model will have to show
weather the number of Nrf2-positive astrocytes increases in chronically demyelinated lesions in the
cuprizone model (i.e. 13 weeks cuprizone intoxication).
Our findings indicate an early oligodendrocyte-mediated defense attempt against oxidative stress via
the functional induction of Nrf2. However, this attempt obviously fails to prevent neuroinflammation
and the loss of oligodendrocytes. Faster (i.e. during the first stages of lesion formation) activation of
astroglial Nrf2 by pharmacological interventions therefore might help to prevent lesion progression.
Although the pathological mechanisms of cuprizone fundamentally differ from neurological diseases
such as MS, it perfectly mimics basic mechanisms of brain-intrinsic inflammation and subsequent
axonal damage. With respect to Nrf2-activation, we show herein that during initial cuprizone-
intoxication, the Nrf2 system gets activated within the damaged areas such as the CC, whereas the
cortical grey matter showed lower Nrf2-activity. However, similar to the human situation, this
potentially protective attempt fails to rescue oligodendrocytes and to prevent demyelination in wild
type animals.
Regarding the source of free radicals in the cuprizone model, Liu and colleagues recently identified
microglia as important producers of ROS in this model. Furthermore, they describe the microglial Hv1
channel as a key factor for this ROS-production (Liu et al. 2015).
Until today, it is not completely clear why oligodendrocytes are selectively vulnerable to cuprizone
intoxication. However, the mechanism by which cuprizone is thought to unfold its toxicity is via
disturbing both mitochondrial functions as well as important detoxifying enzymes such as superoxide
dismutase (Faizi et al. 2016). Oligodendrocytes, in contrast to other glia cells, display a high metabolic
activity and membrane synthesis rate under physiological conditions. A high ATP-synthesis rate
causes the formation of hydrogen peroxide as a toxic byproduct, therefore leading to elevated
oxidative burden. Furthermore, they have only low concentrations of the anti-oxidative enzyme
glutathione (Thorburne and Juurlink 1996), making them more susceptible to both intrinsic and
extrinsic (i.e. microglia-derived) oxidative challenge. Here, we can show that cuprizone indeed seems
to selectively induce Nrf2 in oligodendrocytes, indicating early and selective oxidative stress in this
cell type.
Taken together, cuprizone-intoxication is a helpful tool to study basic mechanisms of
oligodendrocyte loss, neuroinflammation, oxidative stress and Nrf2-activation.
The role of the astrocytic Nrf2/ARE system for neuroinflammation
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Astrocytes possess a variety of roles in maintaining an optimally suited milieu for neuronal function,
among the maintenance of redox potential (Zhang and Jiang 2015). In the presence of an insult
however, astrocytes amplify the inflammatory process that is initiated by microglia (Crotti and Glass
2015; Saijo et al. 2009). The importance of (dysfunctional) astrocytes for the propagation of
inflammation has been well demonstrated for distinct neurological diseases such as Alzheimer`s,
Alexander`s and Huntington`s disease (Crotti and Glass 2015; Olabarria et al. 2015; Zhang and Jiang
2015). Astrocytes produce chemokines such as CXCL1, CCL2, CXCL10 or CCL11 that influence
microglia reactivity (Clarner et al. 2015; Hennessy et al. 2015; Parajuli et al. 2015). Another well-
described mechanism by which microglia get activated is via increased tissue levels of ROS (Ishihara
et al. 2015; Liu et al. 2015; Qiu et al. 2015). Reduced concentrations of ROS therefore might
efficiently inhibit neuroinflammation. Here, we provide evidence that the consistent hyperactivation
of Nrf2 signaling in astrocytes prevents the formation and progression of demyelinated lesions.
Furthermore, the number of astrocytes and the induction of CXCL10 were unchanged in Keap1-KO
mice. Therefore, the most obvious hypothesis explaining our results is that hyperactivated Nrf2 leads
to enhanced detoxification of radicals within the tissue, thereby inhibiting neuroinflammation and
protecting oligodendrocytes and axons. Future studies will have to analyze the levels of ROS/RNS
within the brain of cuprizone-fed Keap1-KO animals.
A less obvious but fully relevant hypothesis to explain our results is that Nrf2-dependent changes in
the release of anti-inflammatory mediators might influence the reactivity and diversification of
microglia. So far, not much is known about the Nrf2-triggered production of such mediators in the
brain. To address this important point, a detailed bioinformatics approach, both in vitro and in vivo
(gene arrays and pathway analysis), could help to elucidate the role of Nrf2-signalling for modulating
the interplay of different glial cell types.
In summary, our data clearly demonstrate that the astrocyte-specific activation of Nrf2 is sufficient to
prevent the formation of demyelinating lesions and neuroinflammation in a non-autoimmune- driven
MS model. The identification of the underlying mechanisms that regulate these processes are of
upmost importance to (A) gain a deeper understanding of MS lesion progression and (B) to develop
novel therapeutic strategies.
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Table 1 Oxidative stress responses in the cuprizone model
Affymetrix gene array data of 1 week cuprizone-fed wild type animals are shown. Gene ontologies
related to oxidative stress and defenses are shown. More detailed information including gene
symbols of regulated genes are given in the supplementary table 1.
Figure 1 Nrf2-target gene expression in the cuprizone model.
Array results were confirmed in additional animals after 1 week cuprizone treatment by RT-qPCR.
Results for Hmox1 (heme oxygenase), GCLC (glutamate-cysteine ligase, catalytic subunit) and TxnRD1
(Thioredoxin reductase 1) are shown (n=6).
*p <0.05; **p<0.01, ***p<0.001.
Figure 2 Cuprizone induces Nrf2-activity in the mouse brain.
(A) Shows the cumulative results of luminescence intensity measured in vivo in luc-ARE mice fed
cuprizone or normal chow for 1 week. (B) shows representative examples of these measurements.
Higher luminescence intensity indicates induced Nrf2 activity in the brain.. (C) Ex vivo analysis at the
end of the experiment showed highest luminescence signal within the CC, a region especially
vulnerable to cuprizone intoxication. *p <0.05; **p<0.01
Figure 3 Cuprizone intoxication increases Nrf2-activation in oligodendrocytes
In (A), results of an immunohistochemical staining against Nrf2 of control animals and animals fed
cuprizone for 1 and 3 weeks are shown. Staining-intensity against Nrf2 increased with feeding
cuprizone. (B) and (C) display double stainings against Nrf2 and the cellular markers GFAP and Olig2.
Oligodendrocytes can clearly be identified as the main responsive cells to cuprizone-intoxication with
respect to Nrf2-accumulation within the cell. Only very low numbers of Nrf2-positive astrocytes were
observed.
Figure 4 Nrf2 hyperactivation ameliorates cuprizone toxicity
In (A), typical (immuno-)histochemical results of control animals and animals fed cuprizone for 3
weeks are shown. Myelin staining intensity loss (LFB) was markedly reduced within the CC of
cuprizone-fed Keap1-KO animals. Furthermore, the numbers of Olig2-positive cells were higher,
whereas microgliosis and the accumulation of APP+ bulbs were less severe in Keap1-KO mice
compared to wild type animals. In (B), quantifications of cell numbers and APP+ bulbs within the CC
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are shown. Scale bars: 150µm in the upper row; 50µm in lower rows. *p <0.05; **p<0.01;
***p<0.001
Figure 5 Astrocyte responses are unchanged in Keap1-KO mice
The increase of astrocyte numbers did not differ between cuprizone-fed wild type and Keap1-KO
mice after 3 weeks. Representative pictures of GFAP-staining are shown in (A). Quantification of cell
numbers (B) did reveal a comparable increase in cell numbers in both genotypes compared to mice
receiving normal show. The expression of astrocyte-derived chemokine CXCL10 did not differ in both
genotypes, indicating similar pro-inflammatory astrocytic responses. Scale bar: 50µm; *p <0.05;
**p<0.01; ***p<0.001
Supplementary table 1. Selected gene ontologies related to oxidative stress and defense
Gene expression was analyzed using the GeneChip® Mouse Gene 1.0 ST Array (Affymetrix, Santa
Clara, CA, USA) in independent triplicates. Total RNA was isolated and quantified from the CC
(Nanodrop). RNA quality was assessed as published (Krauspe et al. 2015) and probes prepared and
hybridized according to the Ambion whole-transcript expression and the Affymetrix whole-transcript
terminal labelling and control kit manuals. For a more detailed protocol see (Krauspe et al. 2015).
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oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of
molecular oxygen to two molecules of water 6 60.00 5.7326
GO:0016645 oxidoreductase activity, acting on the CH-NH group of donors 9 34.62 4.6660
GO:0016175 superoxide-generating NADPH oxidase activity 3 37.50 2.8757
GO:0016835 carbon-oxygen lyase activity 11 18.33 2.6266
GO:0016628 oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor 5 25.00 2.5701
GO:0016491 oxidoreductase activity 95 12.79 3.9571
GO:2000377 regulation of reactive oxygen species metabolic process 15 30.00 5.3186
GO:0000302 response to reactive oxygen species 22 20.95 4.4302
GO:0070482 response to oxygen levels 35 15.70 3.6830
GO:0050665 hydrogen peroxide biosynthetic process 3 42.86 3.1914
GO:0060263 regulation of respiratory burst 3 37.50 2.8757
GO:0045730 respiratory burst 3 37.50 2.8757
WP1496 oxidative damage 13 30.95 3.6021
MP:0005388 respiratory system phenotype 157 14.08 2.0718
Table 1: Gene ontologies related to oxidative stress and numbers of changed genes in response to short-term cuprizone exposure
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HPRT (reference gene) GCTGGTGAAAAGGACCTCT CACAGGACTAGAACACCTGC
Table 2 Primer sequences used for RT-qPCR
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Antibody Host protein Dilution AG Retrival Supplier Catalogue No.
APP mouse Amyloid precursor protein 1:5000 10’ Tris/EDTA Millipore, MAB 348
IBA1 rabbit Ionized calcium-binding adaptor molecule (microglia/macrophages)  1:10000 10’ Tris/EDTA Wako, 019-19741
Olig2 rabbit Oligodendrocyte transcription factor 2 1:2000 Tris/EDTA Millipore, AB9610
Olig2 mouse Oligodendrocyte transcription factor 2 1:1000 20’ Citrate Millipore, MABN50
GFAP rabbit Glial fibrillary acidic protein 1:1000 Tris/EDTA Encore, RPCA-GFAP
GFAP goat Glial fibrillary acidic protein 1:100 20’ Citrate Santa Cruz, sc6170
NRF2 rabbit Nuclear factor erythroid 2-related factor 2 1:100 20’ Citrate GeneTex, GTX103322
Table 3 Primary antibodies used in this study
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Antibody Host Directed against Dilution Supplier Catalogue No.
Biotinylated anti-mouse IgG Horse Secondary Ab against mouse IgGs 1:50 Vector Laboratories BA-2000
Biotinylated anti-rabbit IgG Goat Secondary Ab against rabbit IgGs 1:50 Vector Laboratories BA-1000
594 fluorescent anti-mouse IgG Goat Secondary Ab against mouse IgGs 1:500 Life Technologies, A11032
594 fluorescent anti-goat IgG Donkey Secondary Ab against goat IgGs 1:500 Life Technologies, A11058
Table 4 Secondary antibodies used in this study
Page 27 of 29























Z Score FisherExactP gene symbols
GO:0016717 oxidoreductase activity, acting
on paired donors, with oxidation
of a pair of donors resulting in
the reduction of molecular
oxygen to two molecules of
water
MF 6 10 10 60 100 5,7326 0,0001 4833423E24Rik|Fads3|Sc5d|Scd1|S
cd2|Scd3
GO:0016645 oxidoreductase activity, acting
on the CH-NH group of donors




MF 3 8 8 37,5 100 2,8757 0,0269 Cyba|Cybb|Ncf1
GO:0016835 carbon-oxygen lyase activity MF 11 60 60 18,33 100 2,6266 0,0182 Agxt2l1|Alkbh1|Car12|Car14|Car2|C
ar3|Eno4|Fasn|Hadha|Thnsl2|Tor3a
GO:0016628 oxidoreductase activity, acting
on the CH-CH group of donors,
NAD or NADP as acceptor
MF 5 20 20 25 100 2,5701 0,0261 Dhcr24|Dhcr7|Fasn|Srd5a1|Tm7sf2


















GO:2000377 regulation of reactive oxygen
species metabolic process
BP 15 50 51 30 98,04 5,3186 0 Cdkn1a|Cryab|Foxm1|Gadd45a|Gstp
1|Ier3|Il18|Nfe2l2|Tfap2a|Tgfb1|Thbs
1|Trim30a|Trp53|Tspo|Xdh
GO:0000302 response to reactive oxygen
species
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GO:0050665 hydrogen peroxide biosynthetic
process
BP 3 7 7 42,86 100 3,1914 0,0179 Cyba|Cybb|Ncf1
GO:0060263 regulation of respiratory burst BP 3 8 8 37,5 100 2,8757 0,0269 Dusp10|Rac2|Rps19
GO:0045730 respiratory burst BP 3 8 8 37,5 100 2,8757 0,0269 Cyba|Ncf1|Slc11a1
WP1496 oxidative damage WP 13 42 44 30,95 95,45 3,6021 0,0014 Bcl2|C1qa|C1qb|C1qc|C1ra|C3ar1|C
4b|C5ar1|Cdkn1a|Cdkn1b|Gadd45a|
Pcna|Tnfrsf1b
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